Mr. Christopher Wood has been publishing his renowned weekly investment report GREED & fear since July 1996. He has been ranked No. 1 Equity Strategist in the Asia Money polls between 2002-2004 and 2006-2022. In 2005 his employer did not enter the poll. Wood was also the author of three acclaimed books. “Boom and Bust:
Boya Zhen joined Jefferies’ China/HK Consumer Team in September 2019. Prior to this, Boya had nearly two years’ equity research experience, primarily focused on the China Consumer discretionary and HK Retail sectors. Boya graduated from USC with a MSc in Financial Engineering. She passed all three levels of the CFA Program and is a FRM
Bhaskar Basu covers Indian metals and mining/ steels and India Financials (Non-Banks). He has around 16 years of sell side research experience. Bhaskar joined Jefferies in June of 2015, following over 7 years at Bank of America Merrill Lynch as the lead analyst covering Indian metals and mining, steel and coal sector. Prior to this,
I have covered India Energy since 2008, India Specialty Chemicals since 2021 What I am Known For How I am Different Key Research Highlights
Alok Dalal joined Jefferies in December of 2022, following 14 years as a senior analyst covering the Indian Healthcare sector at CLSA India, Motilal Oswal and BNP Paribas. Alok began his equity research career in 2005, and has covered telecom, aviation and healthcare sectors What I am Known For How I am Different Key Research
Akshat Agarwal joined Jefferies in March 2020, covering the Indian IT services, Telecom and Gaming Sectors as lead analyst. He has been on the sell side for nearly 15 years with prior stints with CLSA and Nomura. Technology IT Services & Software What I am Known For How I am Different Key Research Highlights Corporate
Abhinav Sinha is a research analyst covering the India real estate sector and equity strategy. What I am Known For How I am Different Key Research Highlights
What I am Known For Actively compare coverage commentary with global peers to improve accuracy. How I am Different Sector: Cover a total of 19 stocks across India Pharma, CROs, and Hospitals. Top Pick: In India Pharma/Healthcare, our preference is for hospitals, and are selectively positive on CDMO and pharma. In our view, Indian hospitals
Anne Ling has over 25 years of experience in equity research, focusing on greater China consumer. What I am Known For How I am Different Consumer Discretionary CTF: We think CTF has been consistent with its branding strategy, and Its franchising model plus POS system has ensured healthy sell through and strong profitability. We thus